Editorial Board About Us

Depression

All articles from this key word are listed below.

Volume 5, Number 4 Review Articles

Androgen Replacement Therapy in the Aging Male

Treatment Update

Jeremy B Myers Randall B Meacham

Depression Androgen Testosterone Hypogonadism Erectile dysfunction Andropause Hormone replacement Male osteoporosis Prostatecancer Sarcopenia

Volume 5, Number 3 Meeting Reviews

Best of the 2003 AUA Annual Meeting

Highlights from the 2003 Annual Meeting of the American Urological Association, April 26-May 1, 2003

Kazumasa Torimoto Matthew B Gretzer Michael Dobrovits Mesut Remzi Allan J Pantuck Arie S Belldegrun Bob Djavan Randall B Meacham Dean G Assimos Michael K Brawer Claus G Roehrborn Jacob Rajfer J Curtis Nickel Michael B Chancellor Alan W Partin Ellen Shapiro

Prostate cancer Renal cell carcinoma Benign prostatic hyperplasia Depression Bladder cancer Lower urinary tract symptoms Urinary tract infection Prostate-specific antigen Nephrolithiasis Overactive bladder Radical prostatectomy Peyronie’s disease Gleason score Transrectal ultrasound Erectile dysfunction Chronic prostatitis/chronic pelvic pain syndrome Acute urinary retention International Prostate Symptom Score Bacille Calmette-Guérin therapy Chronic Prostatitis Symptom Index MTOPS trial PLESS study Prostate tumor markers SELDI-TOF

Volume 17, Number 2 Review Articles

Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Mangement Update

Claire Dunphy Alexis E Te Bilal Chughtai Leanna Laor Steven A Kaplan

This article provides an overview of current data on the relationship between depression and lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH), with a focus on pathophysiology and patient management implications. Review of the literature indicated a clear relationship between LUTS secondary to BPH and depression. It is unknown whether this relationship is bidirectional or unidirectional. Depression is associated with the impact of LUTS on quality of life in men with BPH. Research suggests that depression alters the experience of LUTS in this population. Medical and surgical treatments for BPH may impact quality of life and, therefore, depression. Results conflict on the exact nature of the relationship examined, and on the extent to which the relationship may be attributed to physiological factors such as inflammation. Practicing clinicians should consider using a brief self-administered scale to assess for depression in patients with BPH. There is a clear need for additional research to decisively determine the nature of the relationship between LUTS secondary to BPH and depression, as well as the extent to which change in either condition may be affected by the other. [Rev Urol. 2015;17(2):51-57 doi: 10.3909/riu0658] © 2015 MedReviews®, LLC

Benign prostatic hyperplasia Depression Lower urinary tract symptoms

Volume 21, Number 4 Review Articles

Long-term Consequences of Medical Therapy for Benign Prostatic Hyperplasia

Management Update

Steven A Kaplan Vannita Simma-Chiang Eric M Bortnick

Benign prostatic hyperplasia (BPH) is a common disease in men. Although transurethral resection of the prostate (TURP) is the gold standard therapy for treatment of BPH and associated lower urinary tract symptoms (LUTS), many patients choose to avoid surgery and instead choose medical therapy. Until recently, medical therapy for BPH has been thought to be both safe and effective. However, new studies have shown that some of these medications can have significant neurocognitive, psychiatric, and sexual side effects, including dementia and depression. As most patients taking these medications will continue them for the long term, it is vital for physicians to explain these potential risks to the patient prior to prescribing them for a quality-of-life condition. [Rev Urol. 2019;21(4):154–157] © 2020 MedReviews®, LLC

Benign prostatic hyperplasia Medical therapy Depression Dementia 5-Alpha-reductase inhibitors alpha-blockers